Preemptive Therapy for Infants Showing Early Signs of Autism

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 20, 2021

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2021.3298?guestAccessKey=4de62efc-31a1-4b0d-ae0f-fd3c858b2253&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092021

What the Study Did: This randomized clinical trial of 103 infants found that a preemptive intervention for autism spectrum disorder (ASD) among infants showing early signs of ASD led to reduced ASD symptom severity across early childhood and reduced the odds of an ASD diagnosis at 3-years-old.

Authors: Andrew J. O. Whitehouse, Ph.D., of the University of Western Australia in Perth, Australia, is the corresponding author.

(doi:10.1001/jamapediatrics.2021.3298)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #